Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-01

Clinical Trial Update: Glutamate, Hyperarousal and Restless Legs Syndrome

View source ↗

Summary

A clinical trial update from Johns Hopkins University reports completion of a study examining glutamate, hyperarousal, and Restless Legs Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Restless Legs Syndrome | Status: COMPLETED